Security key
09058V103
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX)
CUSIP: 09058V103
Q3 2013 13F Holders as of 30 Sep 2013
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 249,150,204
- Total 13F shares
- 90,679
- Share change
- +39,554
- Total reported value
- $660,000
- Price per share
- $7.28
- Number of holders
- 4
- Value change
- +$460,329
- Number of buys
- 3
- Number of sells
- 1
Report period
Q3 2013
Institutions
4
Top holders
4
BCRX full security history
Newer quarter: Q4 2013
Previous quarter: Q2 2013
BIOCRYST PHARMACEUTICALS INC SEC filings
BIOCRYST PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09058V103
Recent filing periods:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13F
Large-stake signal
No latest 13D/G holder appears in this grouped view.
Evidence coverage
3 holder rows
Latest evidence as of 30 Jun 2013.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
Company
|
0.01%
|
$46,000
29,974 shares
|
— | 30 Jun 2013 |
| Joel Isaacson & Co., LLC |
13F
Company
|
0%
|
$19,000
12,000 shares
|
— | 30 Jun 2013 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$14,000
9,151 shares
|
— | 30 Jun 2013 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) as of Q3 2013
As of 30 Sep 2013,
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,679 shares.
The largest 4 holders included
PDT Partners, LLC, WELLS FARGO & COMPANY/MN, Joel Isaacson & Co., LLC, and Dynamic Technology Lab Pte Ltd.
This page lists
4
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2013 vs Q2 2013 Across Filers
Q2 2013 holders
3
Q3 2013 holders
4
Holder diff
1
| Investor | Q2 2013 Shares | Q3 2013 Shares | Share Diff | Share Chg % | Q2 2013 Value $ | Q3 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.